Literature DB >> 29927331

Low- Versus High-Risk Rectal Cancer Based on MRI Features: Outcomes in Patients Treated Without Neoadjuvant Chemoradiotherapy.

Xiao-Xuan Jia1, Yi Wang1, Jin Cheng1, Xun Yao1, Mu-Jun Yin2, Jing Zhou2, Ying-Jiang Ye2.   

Abstract

OBJECTIVE: The objective of this study was to compare the prognoses of patients with low- and high-risk rectal cancer detected by MRI who were treated without neoadjuvant chemoradiotherapy (NCRT) and to determine independent risk factors.
MATERIALS AND METHODS: This retrospective study included 185 patients with pathologically proven rectal adenocarcinoma who were treated without NCRT. Cancer was defined as high risk if one or more of the following factors were present: extramural depth of tumor invasion greater than 5 mm or stage T4a or T4b for tumor in the mid or high rectum; involvement of intersphincteric space, levators, or adjacent organs for tumor in the low rectum; extramural venous invasion (EMVI); or circumferential resection margin (CRM) involvement. Patients without any of those risk factors were placed in the low-risk group. The Kaplan-Meier method and Cox proportional hazards regression model were used to compare the survival outcomes between the two groups and to investigate the univariate and multivariate influences of the risk factors.
RESULTS: Cancer was deemed to be low risk in 65 (35.1%) patients and high risk in 120 (64.9%) patients. The two patient groups had statistically significant differences in 3-year actuarial overall survival (OS; 100% vs 88.3%, p = 0.0044), disease-free survival (DFS; 92.3% vs 60.0%, p < 0.0001), and local recurrence (LR; 1.5% vs 10.0%, p = 0.0297). CRM involvement was identified as an independent risk factor for OS (hazard ratio [HR], 4.78; 95% CI, 1.24-18.45), DFS (HR, 2.44; 95% CI, 1.24-4.81), and LR (HR, 3.92; 95% CI, 1.07-14.41). Moreover, EMVI was identified as an independent risk factor for DFS (HR, 2.46; 95% CI, 1.28-4.74).
CONCLUSION: The LR and long-term survival of patients in the low-risk group were more favorable than those of patients in the high-risk group. EMVI and CRM status were independent risk factors.

Entities:  

Keywords:  MRI; circumferential resection margin; extramural vascular invasion; rectal cancer

Mesh:

Substances:

Year:  2018        PMID: 29927331     DOI: 10.2214/AJR.17.18980

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  5 in total

1.  MRI-defined high-risk rectal cancer patients: outcome comparison between neoadjuvant chemoradiotherapy plus TME and TME plus adjuvant chemotherapy or TME alone.

Authors:  Xiaoxuan Jia; Peiyi Xie; Liang Bi; Xiaochun Meng; Ziqiang Wang; Nan Hong; Yi Wang
Journal:  Br J Radiol       Date:  2021-02-16       Impact factor: 3.039

2.  Structured Reporting of Rectal Cancer Staging and Restaging: A Consensus Proposal.

Authors:  Vincenza Granata; Damiano Caruso; Roberto Grassi; Salvatore Cappabianca; Alfonso Reginelli; Roberto Rizzati; Gabriele Masselli; Rita Golfieri; Marco Rengo; Daniele Regge; Giuseppe Lo Re; Silvia Pradella; Roberta Fusco; Lorenzo Faggioni; Andrea Laghi; Vittorio Miele; Emanuele Neri; Francesca Coppola
Journal:  Cancers (Basel)       Date:  2021-04-28       Impact factor: 6.639

Review 3.  Recurrence Risk after Radical Colorectal Cancer Surgery-Less Than before, But How High Is It?

Authors:  Erik Osterman; Klara Hammarström; Israa Imam; Emerik Osterlund; Tobias Sjöblom; Bengt Glimelius
Journal:  Cancers (Basel)       Date:  2020-11-09       Impact factor: 6.639

Review 4.  Radiomics and Magnetic Resonance Imaging of Rectal Cancer: From Engineering to Clinical Practice.

Authors:  Francesca Coppola; Valentina Giannini; Michela Gabelloni; Jovana Panic; Arianna Defeudis; Silvia Lo Monaco; Arrigo Cattabriga; Maria Adriana Cocozza; Luigi Vincenzo Pastore; Michela Polici; Damiano Caruso; Andrea Laghi; Daniele Regge; Emanuele Neri; Rita Golfieri; Lorenzo Faggioni
Journal:  Diagnostics (Basel)       Date:  2021-04-23

Review 5.  MRI-detected extramural venous invasion of rectal cancer: Multimodality performance and implications at baseline imaging and after neoadjuvant therapy.

Authors:  Akitoshi Inoue; Shannon P Sheedy; Jay P Heiken; Payam Mohammadinejad; Rondell P Graham; Hee Eun Lee; Scott R Kelley; Stephanie L Hansel; David H Bruining; Jeff L Fidler; Joel G Fletcher
Journal:  Insights Imaging       Date:  2021-08-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.